Pulmonary embolism classification: Difference between revisions
| Line 16: | Line 16: | ||
*Based on characteristic of the embolus: | *Based on characteristic of the embolus: | ||
**Situated centrally within the vascular lumen | **Situated centrally within the vascular lumen | ||
**Occludes a vessel. | **Occludes a vessel | ||
**It also causes distention of the involved vessel. | |||
Acute PE can be further classified as [[Pulmonary embolism classification scheme#Massive PE|Massive pulmonary embolism]] or [[Pulmonary embolism classification scheme#Submassive PE|Submassive pulmonary embolism]] or [[Pulmonary embolism classification scheme#Low-risk PE|Low-risk pulmonary embolism]]. | |||
==Chronic PE== | ==Chronic PE== | ||
Revision as of 16:24, 7 November 2011
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism classification On the Web |
|
Directions to Hospitals Treating Pulmonary embolism classification |
|
Risk calculators and risk factors for Pulmonary embolism classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Synonyms and keywords: PE
Overview
Pulmonary embolism is classified in two different ways based upon:
- Time of appearance of symptoms & Size of embolus : Acute vs Chronic
- Severity of the disease : Massive vs Submassive vs Low-risk
Acute PE
Pulmonary embolism is called acute, if the embolism is
- Based on time of appearance of Symptoms:
- Develop symptoms and signs immediately after obstruction of pulmonary vessels.
- Based on characteristic of the embolus:
- Situated centrally within the vascular lumen
- Occludes a vessel
- It also causes distention of the involved vessel.
Acute PE can be further classified as Massive pulmonary embolism or Submassive pulmonary embolism or Low-risk pulmonary embolism.
Chronic PE
Chronic pulmonary embolism is a consequence of incomplete resolution of pulmonary embolism.
It has the following characteristic:
- Based on time of appearance of Symptoms:
- Develop slowly progressive dyspnea over a period of years due to pulmonary hypertension.
- Based on characteristic of the embolus[1]:
- Embolus is eccentric and Contiguous with the vessel wall
- Embolus reducing the arterial diameter by ≥50%
- Evidence of recanalization within the thrombus
- Presence of an arterial web
Massive PE
In the past, "massive pulmonary embolism" has been defined on the basis of angiographic burden of emboli by using the Miller Index[2]. This is a retrospective diagnosis based upon the pulmonary angiogram that does not inform prospective decisions.
Recently American heart association[3] has proposed the following definition for Massive PE: Acute pulmonary embolism with sustained hypotension (systolic blood pressure <90 mm Hg for at least 15 minutes or requiring inotropic support, not due to a cause other than PE, such as arrhythmia, hypovolemia, sepsis, or left ventricular [LV] dysfunction), pulselessness, or persistent profound bradycardia (heart rate <40 bpm with signs or symptoms of shock).
Submassive PE
American heart association[3] has proposed the following definition for Submassive PE: "Acute PE without systemic hypotension (systolic blood pressure ≥90 mm Hg) but with either RV dysfunction or myocardial necrosis."
Low-risk PE
American heart association[3] has proposed the following definition for Low-risk PE: "Acute PE and the absence of the clinical markers of adverse prognosis that define massive or submassive PE."
References
- ↑ Castañer E, Gallardo X, Ballesteros E, Andreu M, Pallardó Y, Mata JM; et al. (2009). "CT diagnosis of chronic pulmonary thromboembolism". Radiographics. 29 (1): 31–50, discussion 50-3. doi:10.1148/rg.291085061. PMID 19168835.
- ↑ Miller GA, Sutton GC, Kerr IH, Gibson RV, Honey M (1971). "Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism". Br Heart J. 33 (4): 616. PMID 5557502.
- ↑ 3.0 3.1 3.2 Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ; et al. (2011). "Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association". Circulation. 123 (16): 1788–830. doi:10.1161/CIR.0b013e318214914f. PMID 21422387.